Ministry of Health logo

The Ministry of Health announced today, Feb. 18, that the National Scientific Committee for Infectious Diseases approved the administration of only one dose of COVID-19 vaccine for those who have been previously infected by the coronavirus.

 

The dose will be given six months after recovery from the disease, the ministry said on its official Twitter account, adding that it will operate as a trigger for natural immunity that has already been developed.

 

According to data compiled by Argaam, the ministry announced the roll-out of the second phase of the COVID-19 vaccination campaign across the Kingdom.

 

Moreover, the Saudi Food & Drug Authority (SFDA) authorized the use of the British AstraZeneca's COVID-19 vaccine, developed in cooperation with the University of Oxford.

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Related News

SFDA ratifies registration of AstraZeneca COVID-19 vaccine
Saudi Ministry of Health launches second phase of COVID-19 vaccination

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2024, Argaam Investment, All Rights Reserved
Call Request